Mackenzie Financial
AXSM icon

Mackenzie Financial’s Axsome Therapeutics AXSM Stock Holding History

Mackenzie Financial’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$574K Buy
+2,347
New +$509K ﹤0.01% 1291
2026
Q1 		– Sell
-3,382
Closed -$502K – 1458
2025
Q4 		$502K Hold
3,382
– – ﹤0.01% 1222
2025
Q3 		$411K Buy
3,382
+1,097
+48% +$124K ﹤0.01% 1297
2025
Q2 		$239K Sell
2,285
-54
-2% -$5.72K ﹤0.01% 1482
2025
Q1 		$273K Buy
+2,339
New +$266K ﹤0.01% 1413
2024
Q4 		– Sell
-2,339
Closed -$210K – 1701
2024
Q3 		$210K Buy
+2,339
New +$204K ﹤0.01% 1366

Other funds holding AXSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Mackenzie Financial's AXSM Position: Q2 2026 in Review

Mackenzie Financial opened a new position in Axsome Therapeutics (AXSM) in Q2 2026: 2,347 shares worth $574K. The stake represents ﹤0.01% of the portfolio and ranks #1291 among its holdings. This is a return to the name: Mackenzie Financial previously reported a position in AXSM as recently as Q4 2025.

Mackenzie Financial first reported a position in AXSM in Q3 2024 and has held it in 6 quarters since. 506 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • Mackenzie Financial held 2,347 shares of Axsome Therapeutics worth $574K as of Q2 2026.
  • Axsome Therapeutics was a new Mackenzie Financial position in Q2 2026.
  • Axsome Therapeutics made up ﹤0.01% of Mackenzie Financial's portfolio in Q2 2026, its #1291 holding.
  • Mackenzie Financial first reported a position in Axsome Therapeutics in Q3 2024 and has held it in 6 quarters since.
  • 506 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on Mackenzie Financial's 13F filing for Q2 2026, filed 13 Aug 2026.